Effects of magnolol (5,5′-diallyl-2,2′-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats

Life Sciences

Volumn 80, Issue 5, 2007, Pages 468-475

  Sohn, Eun Jin ^a   Kim, Chan Sik ^a   Kim, Young Sook ^a   Jung, Dong Ho ^a   Jang, Dae Sik ^a   Lee, Yun Mi ^a   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Diabetic nephropathy; Goto Kakizaki rat; Magnolol

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; COLLAGEN TYPE 4; GLUCOSE; INSULIN; MAGNOLOL; MESSENGER RNA; SORBITOL; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; GLOMERULUS; GLUCOSE BLOOD LEVEL; GOTO KAKIZAKI RAT; INSULIN BLOOD LEVEL; MAGNOLIACEAE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PROTEIN URINE LEVEL; RAT;

ANIMALS; BIPHENYL COMPOUNDS; BLOOD GLUCOSE; COLLAGEN TYPE IV; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; INSULIN; ISLETS OF LANGERHANS; KIDNEY CORTEX; LIGNANS; MAGNOLIA; MALE; PLANT BARK; PLANT ROOTS; PROTEINURIA; RATS; RATS, INBRED STRAINS; SORBITOL; TRANSFORMING GROWTH FACTOR BETA1;

MAGNOLIA OFFICINALIS;

EID: 33845764758     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.09.037     Document Type: Article

References (26)

1. Bang K.H., Kim Y.K., Min B.S., Na M.K., Rhee Y.H., Lee J.P., and Bae K.H. Archives of Pharmacal Research 23 (2000) 46-49
2. Chang C.P., Hsu Y.C., and Lin M.T. Magnolol protects against cerebral ischaemic injury of rat heatstroke. Clinical and Experimental Pharmacology and Physiology 376 (2003) 387-392
3. Clements Jr. R.S., Morrison A.D., and Winegard A.I. Polyol pathway in aorta: regulation by hormones. Science 166 (1969) 1007-1008
4. Cohen M.P., Ziyadeh F.N., Lautenslager G.T., Cohen J.A., and Shearman C.W. Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells. The American Journal of Physiology 276 (1999) F684-F690
5. Green D.A., Lattimer S.A., and Sima A.A.F. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. The New England Journal of Medicine 316 (1987) 599-606
6. Hur J. Donguibogam parallel version. Committee of Dongui Bogam Translation (1999), Bupin Publishes Co., Seoul, Korea 1979
7. Ignotz R.A., and Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. Journal of Biochemistry and Molecular Biology 261 (1986) 4337-4345
8. Ikeda K., Sakai Y., and Nagase H. Inhibitory effect of magnolol on tumour metastasis in mice. Phytotherapy Research 17 (2003) 933-937
9. Ishii H., Tada H., and Isogai S. An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-β and protein kinase C activity in cultured mesangial cells. Diabetologia 41 (1998) 362-364
10. Kaneto H., Xu G., Song K.H., Suxuma K., Bonner-Weir S., Sharma A., and Weir G.C. Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. Journal of Biological Chemistry 276 (2001) 31099-31104
11. Kim J.S., Kim H., and Ko J.H. Studies on the processing of herbal medicines (III)-HPLC analysis of magnolol and inhibitory effects on the Formation of advanced glycation endproducts (AGEs) in vitro of unprocessed and processed Magnolia Bark. Korean Journal of Pharmacognosy 33 (2002) 308-311
12. Koyama M., Wada R.C., Sakuraba H., Mizukami H., and Yagihashi S. Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus. The American Journal of Pathology 153 (1998) 537-545
13. Lee K.U., Park J.Y., Kim S.W., Lee M.H., Kim G.S., Park S.K., and Park J.S. Prevalence and associated features of albuminuria in Koreans with NIDDM. Diabetes Care 18 (1995) 793-799
14. Lee Y.M., Kim C.S., Kim Y.S., Sohn E.J., and Kim J.S. Effects of magnolol on the AGEs formation and sorbitol accumulation in STZ-induced diabetic rats. American Diabetes Association's 66th Scientific Sessions (2006) A120
15. Lo Y.C., Teng C.M., Chen C.F., Chen C.C., and Hong C.Y. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochemical Pharmacology 47 (1994) 549-553
16. Marshak S., Leibowitz G., Bertuzzi F., Socci C., Kaiser N., Gross D.J., Cerasi E., and Melloul D. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 48 (1999) 1230-1236
17. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. The New England Journal of Medicine 310 (1984) 356-360
18. Nakazawa T., Yasuda T., and Ohsawa T. Metabolites of orally administrated Magnolia officinalis extract in rats and man and its antidepressant-like effects in mice. The Journal of Pharmacy and Pharmacology 55 (2003) 1583-1591
19. Park J.Y., Kim H.K., Chung Y.E., Kim S.W., Hong S.K., and Lee K.U. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes. Diabetes Care 21 (1998) 530-534
20. Portha B., Serradas P., Bailbe D., Suzuki K., Goto Y., and Giroix M.H. Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes 40 (1991) 486-491
21. Pyo M.K., Lee Y., and Yun-Choi H.S. Anti-platelet effect of the constitutes isolated from the barks and fruits of Magnolia obovata. Archives of Pharmacal Research 25 (2002) 325-328
22. Sato N., Kumatsu K., and Kurumatani H. Late onset of diabetic nephropathy in spontaneously diabetic GK Rats. American Journal of Nephrology 23 (2003) 334-342
23. Schrijvers B.F., De Vriese A.S., and Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocrine Review 25 (2004) 971-1010
24. Sharma K., and Ziyadeh F.N. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator. Diabetes 44 (1995) 1139-1146
25. Velasquez M.T., Bhathena S.J., Ranich T., Schwartz A.M., Kardon D.E., Ali A.A., et al. Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus. Kidney International 64 (2003) 2100-2107
26. Yin X., Zhang Y., Wu H., Zhu X., Zheng X., Jiang S., Zhuo H., Shen J., Li L., and Qiu J. Protective effects of Astragalus saponin i on early stage of diabetic nephropathy in rats. Journal of Pharmacological Sciences 95 (2004) 256-266